Comparative humoral and cellular immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: follow-up through Month 48 in a Phase III randomized study (Q35886612)
Jump to navigation
Jump to search
scientific article published in January 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparative humoral and cellular immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: follow-up through Month 48 in a Phase III randomized study |
scientific article published in January 2014 |
Statements
1 reference
Comparative humoral and cellular immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: follow-up through Month 48 in a Phase III randomized study (English)
1 reference
1 reference
human papillomavirus
29 September 2024
Myron J Levin
1 reference
Mark H Einstein
1 reference
Archana Chatterjee
1 reference
Nahida Chakhtoura
1 reference
Peter Takacs
1 reference
Grégory Catteau
1 reference
Francis J Dessy
1 reference
Philippe Moris
1 reference
Lan Lin
1 reference
Frank Struyf
1 reference
Gary Dubin
1 reference
HPV-010 Study Group
1 reference
1 January 2014
1 reference
1 reference
3455-3465
1 reference
Identifiers
1 reference
1 reference
1 reference